Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 231

Results For "Oval"

2711 News Found

Honeywell teams with AstraZeneca to develop net-gen inhalers to combat global warming
Sustainability | April 11, 2022

Honeywell teams with AstraZeneca to develop net-gen inhalers to combat global warming

Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products


Israel’s TAU breakthrough offers new hope to help people with paralysis walk again
News | April 11, 2022

Israel’s TAU breakthrough offers new hope to help people with paralysis walk again

Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant


LivaNova initiates targeted commercial launch of Essenz patient monitor
Biotech | April 10, 2022

LivaNova initiates targeted commercial launch of Essenz patient monitor

An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe


Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer
Biotech | April 08, 2022

Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer

The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC


Hataali wins US patent for the use of blockchain in advanced medicinal therapy
Digitisation | April 06, 2022

Hataali wins US patent for the use of blockchain in advanced medicinal therapy

The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award


Alvotech and STADA pave way to launching Hukyndra
Biotech | April 06, 2022

Alvotech and STADA pave way to launching Hukyndra

All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved


Novartis announces new organizational structure
Biotech | April 04, 2022

Novartis announces new organizational structure

New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity


USFDA grants priority review to Roche’s Actemra/RoActemra to treat Covid-19
News | April 04, 2022

USFDA grants priority review to Roche’s Actemra/RoActemra to treat Covid-19

If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients


Merck expands manufacturing facility in Virginia to increase HPV vaccine supply
Biotech | April 04, 2022

Merck expands manufacturing facility in Virginia to increase HPV vaccine supply

Supply increase to help meet growing global demand


USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma
Biotech | April 03, 2022

USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma

Yescarta is First CAR T-cell therapy to receive NCCN treatment guideline category 1 recommendation --